tirzepatide kidney damage and chronic disease Not currently a therapy. But this exploratory finding is worth watching closely. 🫘 #ObesityMedicine Dosing:Low-Dose canadian-made Glucagon-like peptide-1 receptor agonists

tirzepatide kidney damage and chronic disease Not currently a therapy. But this exploratory finding is worth watching closely. 🫘 #ObesityMedicine Dosing:Low-Dose canadian-made Glucagon-like peptide-1 receptor agonists

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND) - PMC

Prioritize sleep over an extra training day

canadian-made

Dosing:Low-Dose

The blood pressure benefits appear to be secondary to its metabolic effects rather than direct vasodilatory action, and much of the effect correlates with weight loss